155 related articles for article (PubMed ID: 3258584)
1. Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin.
Simpson DL; Berthold P; Taichman NS
Infect Immun; 1988 May; 56(5):1162-6. PubMed ID: 3258584
[TBL] [Abstract][Full Text] [Related]
2. Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyelocytic HL-60 cell line.
Zambon JJ; DeLuca C; Slots J; Genco RJ
Infect Immun; 1983 Apr; 40(1):205-12. PubMed ID: 6572616
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to leukotoxin of Actinobacillus actinomycetemcomitans.
DiRienzo JM; Tsai CC; Shenker BJ; Taichman NS; Lally ET
Infect Immun; 1985 Jan; 47(1):31-6. PubMed ID: 3965404
[TBL] [Abstract][Full Text] [Related]
4. Early changes in cytosolic calcium and membrane potential induced by Actinobacillus actinomycetemcomitans leukotoxin in susceptible and resistant target cells.
Taichman NS; Iwase M; Lally ET; Shattil SJ; Cunningham ME; Korchak HM
J Immunol; 1991 Nov; 147(10):3587-94. PubMed ID: 1940358
[TBL] [Abstract][Full Text] [Related]
5. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin.
Kelk P; Johansson A; Claesson R; Hänström L; Kalfas S
Infect Immun; 2003 Aug; 71(8):4448-55. PubMed ID: 12874324
[TBL] [Abstract][Full Text] [Related]
6. Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin.
Iwase M; Lally ET; Berthold P; Korchak HM; Taichman NS
Infect Immun; 1990 Jun; 58(6):1782-8. PubMed ID: 2341178
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin.
Rabie G; Lally ET; Shenker BJ
Infect Immun; 1988 Jan; 56(1):122-7. PubMed ID: 3335399
[TBL] [Abstract][Full Text] [Related]
8. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes.
Mangan DF; Taichman NS; Lally ET; Wahl SM
Infect Immun; 1991 Sep; 59(9):3267-72. PubMed ID: 1879940
[TBL] [Abstract][Full Text] [Related]
9. Regulation of leukotoxin in leukotoxic and nonleukotoxic strains of Actinobacillus actinomycetemcomitans.
Spitznagel J; Kraig E; Kolodrubetz D
Infect Immun; 1991 Apr; 59(4):1394-401. PubMed ID: 2004819
[TBL] [Abstract][Full Text] [Related]
10. Effect of Ca2+ on the binding of Actinobacillus actinomycetemcomitans leukotoxin and the cytotoxicity to promyelocytic leukemia HL-60 cells.
Sato N; Takahashi K; Ohta H; Kurihara H; Fukui K; Murayama Y; Taniguchi S
Biochem Mol Biol Int; 1993 Apr; 29(5):899-905. PubMed ID: 8508142
[TBL] [Abstract][Full Text] [Related]
11. Phospholipids inhibit cytotoxic effects of Actinobacillus actinomycetemcomitans leukotoxin on human polymorphonuclear leukocytes.
Ginsburg I; Tsai CC; Wrenn SM; Taichman NS
Inflammation; 1982 Dec; 6(4):365-70. PubMed ID: 7160873
[TBL] [Abstract][Full Text] [Related]
12. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans.
Johansson A; Claesson R; Hänström L; Sandström G; Kalfas S
J Periodontal Res; 2000 Apr; 35(2):85-92. PubMed ID: 10863962
[TBL] [Abstract][Full Text] [Related]
13. Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans.
Kachlany SC; Fine DH; Figurski DH
Infect Immun; 2000 Nov; 68(11):6094-100. PubMed ID: 11035711
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of the leukotoxin gene from Actinobacillus actinomycetemcomitans.
Kolodrubetz D; Dailey T; Ebersole J; Kraig E
Infect Immun; 1989 May; 57(5):1465-9. PubMed ID: 2707855
[TBL] [Abstract][Full Text] [Related]
15. Membranolytic activity of Actinobacillus actinomycetemcomitans leukotoxin.
Taichman NS; Iwase M; Korchak H; Berthold P; Lally ET
J Periodontal Res; 1991 May; 26(3 Pt 2):258-60. PubMed ID: 1831848
[No Abstract] [Full Text] [Related]
16. Lack of lipoprotein-dependent effects on the cytotoxic interactions of Actinobacillus actinomycetemcomitans leukotoxin with human neutrophils.
Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Kalfas S
APMIS; 2002 Dec; 110(12):857-62. PubMed ID: 12645663
[TBL] [Abstract][Full Text] [Related]
17. Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B.
Tsai CC; Shenker BJ; DiRienzo JM; Malamud D; Taichman NS
Infect Immun; 1984 Feb; 43(2):700-5. PubMed ID: 6319288
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of synthetic histatin 5 on leukotoxin from Actinobacillus actinomycetemcomitans.
Murakami Y; Xu T; Helmerhorst EJ; Ori G; Troxler RF; Lally ET; Oppenheim FG
Oral Microbiol Immunol; 2002 Jun; 17(3):143-9. PubMed ID: 12030965
[TBL] [Abstract][Full Text] [Related]
19. Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity.
Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Sandström G; Kalfas S
Eur J Oral Sci; 2001 Oct; 109(5):335-41. PubMed ID: 11695755
[TBL] [Abstract][Full Text] [Related]
20. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity.
Johansson A; Sandström G; Claesson R; Hänström L; Kalfas S
Eur J Oral Sci; 2000 Apr; 108(2):136-46. PubMed ID: 10768727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
